MedPath

To assess the effectiveness of topical EMLA cream in reducing pain during intravenous cannulation by applying over skin in children between age groups 3 years to 12 years and measuring pain using various pain scales

Phase 4
Conditions
Health Condition 1: R69- Illness, unspecified
Registration Number
CTRI/2024/02/062606
Lead Sponsor
THAMIZSELVAN G
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children between age groups 3 years to 12 years requiring non-emergent Intravenous cannulation

2.Parents who are willing to participate in the study and giving informed written consent

Exclusion Criteria

1.Emergency situations requiring immediate intravenous access

2.History of atopy

3.Open wounds or rash on dorsum of hand

4.Hypersensitivity to Eutectic mixture of local anaesthetic cream

5.Facial anomalies( preventing typical facial expressions of pain )

6.Cognitive dysfunction and conditions affecting ability to rate pain

7.Local erythema or blanching following eutectic mixture of local anaesthetic cream application

8.Requiring more than one attempt for cannulation

9.Children with poorly visible veins

10.Parents not willing to participate and give consent for study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in intravenous cannulation pain using eutectic mixture of local anaesthetic cream using visual analog scale pain score and FLACC scale and 4 point pain scaleTimepoint: Outcome (reduction in intravenous cannulation pain assessed using pain scales) will be assessed at specific time based on group which participants randomized. For Group A - assessed after 30 minutes application of placebo <br/ ><br>Group B - assessed after 30 minutes application of EMLA <br/ ><br>Group C - assessed after 60 minutes application of EMLA
Secondary Outcome Measures
NameTimeMethod
To study the timing of application of topical EMLA cream for intravenous cannulation in childrenTimepoint: 30 minutes and 60 minutes application time
© Copyright 2025. All Rights Reserved by MedPath